The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.
Journalists were required to sign non-disclosure agreements, promising not to reveal the location of the multi-million dollar facility, before Medifarm director Adam Benjamin led a convoy to the high-security site.
At the end of a rural road, high security fences topped with barbed wire surrounded a large greenhouse that reporters were not allowed to enter.
“I guess one of the reasons the licensing authority, the Office of Drug Control through federal health, liked what we proposed and awarded our licences is everything’s co-located,” Mr Benjamin said.
Top image: © Premium Collection | Adobe Stock
Source: Cannabis Business Times